{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:41:09Z","timestamp":1780630869245,"version":"3.54.1"},"reference-count":384,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.trsl.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T17:00:32Z","timestamp":1453136432000},"page":"33-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Mast cell activation disease and the modern epidemic of chronic inflammatory disease"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-4244","authenticated-orcid":false,"given":"Lawrence B.","family":"Afrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2016.01.003_bib1","series-title":"World Allergy Organization (WAO) white book on allergy","first-page":"12","article-title":"Introduction and executive summary","author":"Pawankar","year":"2011"},{"key":"10.1016\/j.trsl.2016.01.003_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1939-4551-7-12","article-title":"Allergic diseases and asthma: a global public health concern and a call to action","volume":"7","author":"Pawankar","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.trsl.2016.01.003_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0092-8674(00)81110-1","article-title":"Genetic analysis of autoimmune disease","volume":"85","author":"Vyse","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2016.01.003_bib4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.trsl.2016.01.003_bib5","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2016.01.003_bib6","series-title":"Overcoming obesity: an initial economic analysis\u2014executive summary","first-page":"1","author":"Dobbs","year":"2014"},{"key":"10.1016\/j.trsl.2016.01.003_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.phr.2004.04.005","article-title":"The growing burden of chronic disease in America","volume":"119","author":"Anderson","year":"2004","journal-title":"Public Health Rep"},{"key":"10.1016\/j.trsl.2016.01.003_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01930779","article-title":"Ueber eiter\u2014und bindegewebsk\u00f6rperchen","volume":"28","author":"von Recklinghausen","year":"1863","journal-title":"Virchows Arch"},{"key":"10.1016\/j.trsl.2016.01.003_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF02933937","article-title":"Beitr\u00e4ge zur Kenntnis der Anilinf\u00e4rburgen und ihrer Verwendung in der Mikroskopischen Technik","volume":"13","author":"Ehrlich","year":"1877","journal-title":"Arch Mikrosk Anat"},{"key":"10.1016\/j.trsl.2016.01.003_bib10","first-page":"9","article-title":"Beitr\u00e4ge zur Anatomie und Pathogenese der urticaria simplex und pigmentosa","volume":"6","author":"Unna","year":"1887","journal-title":"Monatschrift der praktischen Dermatologie"},{"key":"10.1016\/j.trsl.2016.01.003_bib11","first-page":"426","article-title":"Urticaria pigmentosa: report of a case with autopsy","volume":"48","author":"Ellis","year":"1949","journal-title":"Arch Pathol"},{"key":"10.1016\/j.trsl.2016.01.003_bib12","first-page":"242","article-title":"Beitr\u00e4ge zur Kenntnis der Chemie and Funktion der Ehrlichschen M\u00e4stzellen","volume":"42","author":"Holmgren","year":"1937","journal-title":"Z Mikrosk Anat Forsch"},{"key":"10.1016\/j.trsl.2016.01.003_bib13","first-page":"279","article-title":"\u00dcber das Vorkommen von Heparin in den Gef\u00e4ssw\u00e4nden und in den Augen","volume":"42","author":"Jorpes","year":"1937","journal-title":"Z Mikrosk Anat Forsch"},{"key":"10.1016\/j.trsl.2016.01.003_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.118.3064.332","article-title":"Histamine in tissue mast cells","volume":"118","author":"Riley","year":"1953","journal-title":"Science"},{"key":"10.1016\/j.trsl.2016.01.003_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1113\/jphysiol.1953.sp004915","article-title":"The presence of histamine in tissue mast cells","volume":"120","author":"Riley","year":"1953","journal-title":"J Physiol (Lond)"},{"key":"10.1016\/j.trsl.2016.01.003_bib16","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jaci.2010.12.1113","article-title":"Toward a global classification of mast cell activation diseases","volume":"127","author":"Molderings","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib17","series-title":"\u201cMast cells\u201d in COPE: cytokines and cells online\u00a0pathfinder encyclopaedia","author":"Ibelgaufts","year":"2015"},{"key":"10.1016\/j.trsl.2016.01.003_bib18","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib19","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","article-title":"The \u03b1 form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis","volume":"96","author":"Schwartz","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.01.003_bib20","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1111\/j.1365-2222.2011.03848.x","article-title":"An increase in serum tryptase even below 11.4 ng\/mL may indicate a mast cell-mediated hypersensitivity reaction: a prospective study in hymenoptera venom allergic patients","volume":"41","author":"Borer-Reinhold","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.01.003_bib21","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.01.003_bib22","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.01.003_bib23","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish network on mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib24","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib25","first-page":"321","article-title":"The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis","volume":"144","author":"Iemura","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2016.01.003_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1600-0625.1995.tb00250.x","article-title":"Mast cell ontogeny and apoptosis","volume":"4","author":"Metcalfe","year":"1995","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib27","doi-asserted-by":"crossref","first-page":"e39117","DOI":"10.1371\/journal.pone.0039117","article-title":"Anti-apoptotic Bfl-1 is the major effector in activation-induced human mast cell survival","volume":"7","author":"Ekoff","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.003_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s10875-007-9153-4","article-title":"Fc\u03b3RI-mediated activation of human mast cells promotes survival and induction of the pro-survival gene Bfl-1","volume":"28","author":"Karlberg","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib29","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1046\/j.1365-2222.2003.01728.x","article-title":"Activation of mast cells by immunoglobulin E-receptor cross-linkage, but not through adenosine receptors, induces A1 expression and promotes survival","volume":"33","author":"M\u00f6ller","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.01.003_bib30","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.178.7.4177","article-title":"Fc\u03b5RI aggregation promotes survival of connective tissue-like mast cells but not mucosal-like mast cells","volume":"178","author":"Ekoff","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib31","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood-2004-12-4792","article-title":"Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim","volume":"106","author":"M\u00f6ller","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.exphem.2006.11.008","article-title":"Bcl-2 and Bcl-XL are indispensable for the late phase of mast cell development from mouse embryonic stem cells","volume":"35","author":"M\u00f6ller","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.trsl.2016.01.003_bib33","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1182\/blood-2006-10-053371","article-title":"NFAT but not NF-\u03baB is critical for transcriptional induction of the prosurvival gene A1 after IgE receptor activation in mast cells","volume":"111","author":"Uller\u00e5s","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib34","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s11033-009-9650-z","article-title":"Molecular regulation of mast cell development and maturation","volume":"37","author":"Liu","year":"2010","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.trsl.2016.01.003_bib35","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1111\/1523-1747.ep12468945","article-title":"Biochemical diagnosis of systemic mast cell disorders","volume":"96","author":"Roberts","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000096442","article-title":"Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome","volume":"142","author":"Sonneck","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib37","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.trsl.2016.01.003_bib39","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/00365520701245744","article-title":"Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder","volume":"42","author":"Molderings","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00251-010-0474-8","article-title":"Comparative analysis of mutation of tyrosine kinase Kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects","volume":"62","author":"Molderings","year":"2010","journal-title":"Immunogenetics"},{"key":"10.1016\/j.trsl.2016.01.003_bib41","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","article-title":"Comprehensive mutational profiling in advanced systemic mastocytosis","volume":"122","author":"Schwaab","year":"2013","journal-title":"Blood"},{"issue":"Supp 1s","key":"10.1016\/j.trsl.2016.01.003_bib42","first-page":"S66","article-title":"The detection of novel KIT mutations in mastocytosis","volume":"133","author":"Chan","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/ced.12000","article-title":"Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis","volume":"38","author":"Chan","year":"2013","journal-title":"Clin Exp Dermatol"},{"issue":"Supp 1s","key":"10.1016\/j.trsl.2016.01.003_bib44","first-page":"S66","article-title":"Genetic background of mastocytosis, a synopsis of cooperative studies conducted by ECNM","volume":"133","author":"Nedoszytko","year":"2013","journal-title":"J Investigative Dermatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1200\/JCO.2010.29.8711","article-title":"Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2016.01.003_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2011-01-331678","article-title":"Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression","volume":"118","author":"Klampfl","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib47","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.4085.4085","article-title":"Genome-wide molecular portrait of aggressive systemic mastocytosis and mast cell leukemia depicted by whole exome sequencing and copy number variation analysis","volume":"126","author":"Soverini","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib48","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2567.2012.03627.x","article-title":"Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics","volume":"137","author":"Haenisch","year":"2012","journal-title":"Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib50","doi-asserted-by":"crossref","first-page":"e76241","DOI":"10.1371\/journal.pone.0076241","article-title":"Familial occurrence of systemic mast cell activation disease","volume":"8","author":"Molderings","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.003_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria, and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5315\/wjh.v3.i1","article-title":"A concise, practical guide to diagnostic assessment for mast cell activation disease","volume":"3","author":"Afrin","year":"2014","journal-title":"World J Hematol"},{"key":"10.1016\/j.trsl.2016.01.003_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","article-title":"Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options","volume":"4","author":"Molderings","year":"2011","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.trsl.2016.01.003_bib54","series-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","first-page":"54","article-title":"Mastocytosis","author":"Horny","year":"2008"},{"key":"10.1016\/j.trsl.2016.01.003_bib55","series-title":"Anaphylaxis and hypersensitivity reactions","first-page":"245","article-title":"Chapter 15: mastocytosis and mast cell activation syndromes presenting as anaphylaxis","author":"Akin","year":"2011"},{"key":"10.1016\/j.trsl.2016.01.003_bib56","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.tips.2011.05.005","article-title":"Mast cells squeeze the heart and stretch the gird: their role in atherosclerosis and obesity","volume":"32","author":"Theoharides","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.trsl.2016.01.003_bib57","doi-asserted-by":"crossref","first-page":"E1677","DOI":"10.1210\/jc.2012-1532","article-title":"Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes","volume":"97","author":"Divoux","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2016.01.003_bib58","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/stem.523","article-title":"Adipose tissue as a dedicated reservoir of functional mast cell progenitors","volume":"28","author":"Poglio","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.trsl.2016.01.003_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2016.01.003_bib60","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1742-4658.2010.07565.x","article-title":"Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in\u00a0vivo","volume":"277","author":"Fujitani","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.trsl.2016.01.003_bib61","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2826.2011.02128.x","article-title":"Central nervous system lipocalin-type prostaglandin D2-synthase is correlated with orexigenic neuropeptides, visceral adiposity and markers of the hypothalamic-pituitary-adrenal axis in obese humans","volume":"23","author":"Elias","year":"2011","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.trsl.2016.01.003_bib62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1478-3231.2008.01839.x","article-title":"New aspects of liver abnormalities as part of the systemic mast cell activation syndrome","volume":"29","author":"Alfter","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.trsl.2016.01.003_bib63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.trsl.2016.01.003_bib64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fimmu.2012.00007","article-title":"Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans","volume":"3","author":"Shi","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib65","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.4049\/jimmunol.177.10.7275","article-title":"Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat","volume":"177","author":"Geoffrey","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib66","doi-asserted-by":"crossref","first-page":"18895","DOI":"10.1073\/pnas.0810246105","article-title":"Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice","volume":"105","author":"Louvet","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.01.003_bib67","first-page":"1000","article-title":"Mast cells in bronchoalveolar lumen of patients with bronchial asthma","volume":"129","author":"Tomioka","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.trsl.2016.01.003_bib68","first-page":"A2399","article-title":"Th2 high asthmatic bronchoalveolar mast cells release less PGD2 and tryptase following acute stimulation","volume":"187","author":"Fajt","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib69","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11882-005-0086-9","article-title":"The re-emergence of the mast cell as a pivotal cell in asthma pathogenesis","volume":"5","author":"Brightling","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.trsl.2016.01.003_bib70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1183\/09059180.00005014","article-title":"Mast cells in human airways: the culprit?","volume":"23","author":"Erjef\u00e4lt","year":"2014","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.trsl.2016.01.003_bib71","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fimmu.2012.00169","article-title":"Role of female sex hormones, estradiol and progesterone, in mast cell behavior","volume":"3","author":"Zierau","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib72","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/039463200601900408","article-title":"Progesterone inhibits mast cell secretion","volume":"19","author":"Vasiadi","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.trsl.2016.01.003_bib73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0301-2115(95)02227-9","article-title":"Immunological aspects of ovarian function: role of the cytokines","volume":"63","author":"Vinatier","year":"1995","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.trsl.2016.01.003_bib74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1126\/science.120.3105.31","article-title":"Mast cells in human atherosclerosis","volume":"120","author":"Cairns","year":"1954","journal-title":"Science"},{"key":"10.1016\/j.trsl.2016.01.003_bib75","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1601","article-title":"Mast cells promote atherosclerosis by releasing proinflammatory cytokines","volume":"13","author":"Sun","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbamem.2012.05.011","article-title":"Connexins in atherosclerosis","volume":"1828","author":"Pfenniger","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2016.01.003_bib77","doi-asserted-by":"crossref","first-page":"e97014","DOI":"10.1371\/journal.pone.0097014","article-title":"Circulating tryptase as a marker for subclinical atherosclerosis in obese subjects","volume":"9","author":"Moreno","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.003_bib78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anndiagpath.2012.04.007","article-title":"Role of mast cell chymase and tryptase in the progression of atherosclerosis: study in 44 autopsied cases","volume":"17","author":"Ramalho","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.trsl.2016.01.003_bib79","first-page":"672","article-title":"Mast cells in atherosclerosis as a source of the cytokine RANKL","volume":"44","author":"Ali","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib80","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/ATVBAHA.114.303570","article-title":"Mast cells as effectors in atherosclerosis","volume":"35","author":"Bot","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2016.01.003_bib81","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1357-4310(00)01747-0","article-title":"The molecular role of mast cells in atherosclerotic cardiovascular disease","volume":"6","author":"Kelley","year":"2000","journal-title":"Mol Med Today"},{"key":"10.1016\/j.trsl.2016.01.003_bib82","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1093\/eurheartj\/eht259","article-title":"Are mast cells the real culprit in atherosclerosis?","volume":"34","author":"Otsuka","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.trsl.2016.01.003_bib83","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.trsl.2016.01.003_bib84","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-9-S1-S1","article-title":"Chronic fatigue syndrome: aetiology, diagnosis and treatment","volume":"9","author":"Avellaneda Fern\u00e1ndez","year":"2009","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.trsl.2016.01.003_bib85","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4088\/PCC.v10n0206","article-title":"A systematic review of chronic fatigue syndrome: don't assume it's depression","volume":"10","author":"Griffith","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.trsl.2016.01.003_bib86","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.jcp.0000193483.89260.a7","article-title":"Chronic fatigue syndrome, mast cells, and tricyclic antidepressants","volume":"25","author":"Theoharides","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.trsl.2016.01.003_bib87","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12974-014-0168-5","article-title":"Isoflavones inhibit poly(I: C)-induced serum, brain, and skin inflammatory mediators\u2014relevance to chronic fatigue syndrome","volume":"11","author":"Vasiadi","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.trsl.2016.01.003_bib88","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4236\/nm.2011.21003","article-title":"An etiological model for myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"2","author":"Jason","year":"2011","journal-title":"Neurosci Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib89","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population\u2014a comparison of the American College of Rheumatology 1990, 2010 and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2016.01.003_bib90","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2377-5-22","article-title":"A chronic fatigue syndrome\u2014related proteome in human cerebrospinal fluid","volume":"5","author":"Baraniuk","year":"2005","journal-title":"BMC Neurol"},{"key":"10.1016\/j.trsl.2016.01.003_bib91","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.trsl.2016.01.003_bib92","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","article-title":"Case-control cohort study of patients' perceptions of disability in mastocytosis","volume":"3","author":"Hermine","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.003_bib93","first-page":"146","article-title":"The presentation, diagnosis and treatment of mast cell activation syndrome: review article","volume":"3","author":"Afrin","year":"2014","journal-title":"Curr Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib94","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10067-010-1474-7","article-title":"Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients","volume":"29","author":"Blanco","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib95","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/03009749709105321","article-title":"Dermal IgG deposits and increase of mast cells in patients with fibromyalgia-relevant findings or epiphenomena?","volume":"26","author":"Enestrom","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib96","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/205873920601900102","article-title":"Fibromyalgia\u2014new concepts of pathogenesis and treatment","volume":"19","author":"Lucas","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.trsl.2016.01.003_bib97","first-page":"146","article-title":"Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia","volume":"30","author":"Salemi","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib98","series-title":"New research in fibromyalgia","first-page":"7","article-title":"The NO\/ONOO-cycle as the cause of fibromyalgia and related illnesses: etiology, explanation and effective therapy","author":"Pall","year":"2006"},{"key":"10.1016\/j.trsl.2016.01.003_bib99","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00535-011-0379-9","article-title":"Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review","volume":"46","author":"Ford","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib100","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/nmo.12250","article-title":"Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS","volume":"26","author":"Di Nardo","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.trsl.2016.01.003_bib101","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/gut.2010.213108","article-title":"The mast cell stabilizer ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome","volume":"59","author":"Klooker","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2016.01.003_bib102","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2036.2009.04041.x","article-title":"Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study","volume":"30","author":"Corinaldesi","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.trsl.2016.01.003_bib103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1590\/S0004-28032011000100008","article-title":"Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine","volume":"48","author":"Bafutto","year":"2011","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/CEG.S18381","article-title":"Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome","volume":"4","author":"Dorofeyev","year":"2011","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib105","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-013-2988-z","article-title":"Mast cells in irritable bowel syndrome and ulcerative colitis: function not numbers is what makes all the difference","volume":"59","author":"Theoharides","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.trsl.2016.01.003_bib106","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1245707","article-title":"Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome","volume":"49","author":"Frieling","year":"2011","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib107","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ajg.2008.94","article-title":"Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms","volume":"104","author":"Cremon","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib108","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2016.01.003_bib109","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5056\/jnm.2011.17.1.14","article-title":"Epidemiology of gastroesophageal reflux disease in Asia: a systematic review","volume":"17","author":"Jung","year":"2011","journal-title":"J Neurogastroenterol Motil"},{"issue":"Suppl 1","key":"10.1016\/j.trsl.2016.01.003_bib110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000151249","article-title":"Epidemiology of non-erosive reflux disease","volume":"78","author":"El-Serag","year":"2008","journal-title":"Digestion"},{"key":"10.1016\/j.trsl.2016.01.003_bib111","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.3748\/wjg.14.5233","article-title":"Heterogeneity of endoscopy negative heartburn: epidemiology and natural history","volume":"14","author":"Pace","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib112","article-title":"Emerging type of heartburn defies drugs, diagnosis","author":"Beck","year":"2012","journal-title":"Wall St J"},{"key":"10.1016\/j.trsl.2016.01.003_bib113","series-title":"Surgical pathology of the GI tract, liver, biliary tract and pancreas","first-page":"232","article-title":"Inflammatory disorders of the esophagus","author":"Bennett","year":"2009"},{"key":"10.1016\/j.trsl.2016.01.003_bib114","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000478-198307000-00005","article-title":"Systemic mastocytosis: extracutaneous manifestations","volume":"7","author":"Brunning","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.trsl.2016.01.003_bib115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/978-1-4684-5344-7_73","article-title":"Mast cell pleomorphism: properties of intestinal mast cells","volume":"216A","author":"Swieter","year":"1987","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.trsl.2016.01.003_bib116","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MAJ.0b013e31821d41dd","article-title":"Polycythemia from mast cell activation syndrome: lessons learned","volume":"342","author":"Afrin","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.trsl.2016.01.003_bib117","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tripleo.2010.11.030","article-title":"Burning mouth syndrome and mast cell activation disorder","volume":"111","author":"Afrin","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.trsl.2016.01.003_bib118","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2016.01.003_bib119","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States, 2003-2008","volume":"57","author":"Persell","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2016.01.003_bib120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrneph.2012.260","article-title":"Resistant hypertension\u2014its identification and epidemiology","volume":"9","author":"Sarafidis","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trsl.2016.01.003_bib121","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2016.01.003_bib122","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJMsa0903829","article-title":"Shattuck Lecture. The hypertension paradox\u2014more uncontrolled disease despite improved therapy","volume":"361","author":"Chobanian","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib123","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-5728(01)00384-8","article-title":"Catecholamines in murine bone marrow derived mast cells","volume":"119","author":"Freeman","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib124","doi-asserted-by":"crossref","first-page":"13607","DOI":"10.1073\/pnas.0403208101","article-title":"Mast cells: a unique source of renin","volume":"101","author":"Silver","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.01.003_bib125","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1016\/S0021-9258(18)34171-1","article-title":"Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases","volume":"257","author":"Reilly","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.01.003_bib126","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ni.f.216","article-title":"New developments in mast cell biology","volume":"9","author":"Kalesnikoff","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib127","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/00004872-200310000-00022","article-title":"A role for cardiac mast cells in the pathogenesis of hypertensive heart disease","volume":"21","author":"Shiota","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.trsl.2016.01.003_bib128","doi-asserted-by":"crossref","first-page":"F1103","DOI":"10.1152\/ajprenal.00374.2007","article-title":"Increased mast cell number in human hypertensive nephropathy","volume":"295","author":"Welker","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2016.01.003_bib129","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.freeradbiomed.2006.12.007","article-title":"Vascular and perivascular nitric oxide release and transport: biochemical pathways of neuronal nitric oxide synthase (NOS1) and endothelial nitric oxide synthase (NOS3)","volume":"42","author":"Chen","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thx.54.1.88","article-title":"Mast cell chymase in pulmonary hypertension","volume":"54","author":"Mitani","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.trsl.2016.01.003_bib131","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1183\/09031936.00033611","article-title":"Mast cells: bridging the gap between pre- and post-capillary pulmonary hypertension?","volume":"37","author":"Montani","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trsl.2016.01.003_bib132","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/2045-8932.97609","article-title":"Mast cell number, phenotype, and function in human pulmonary arterial hypertension","volume":"2","author":"Farha","year":"2012","journal-title":"Pulm Circ"},{"key":"10.1016\/j.trsl.2016.01.003_bib133","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.201202-0335OC","article-title":"Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension","volume":"186","author":"Savai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib134","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1479-5876-5-44","article-title":"The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension","volume":"5","author":"Aller","year":"2007","journal-title":"J Transl Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/157340308785160624","article-title":"Mast cells: pivotal players in cardiovascular diseases","volume":"4","author":"Bot","year":"2008","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.trsl.2016.01.003_bib136","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/er.2011-0013","article-title":"Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases","volume":"33","author":"Xu","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.trsl.2016.01.003_bib137","doi-asserted-by":"crossref","first-page":"5","DOI":"10.14748\/bmr.v6.169","article-title":"Role of adventitia in vascular remodeling in hypertension: a trophobiological view","volume":"6","author":"Chaldakov","year":"1996","journal-title":"Biomed Rev"},{"key":"10.1016\/j.trsl.2016.01.003_bib138","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/187152207780363730","article-title":"Emerging roles of perivascular adipose tissue in regulation of vascular functions","volume":"7","author":"Yang","year":"2007","journal-title":"Immunol Endocr Metabol Agents Medicinal Chem"},{"key":"10.1016\/j.trsl.2016.01.003_bib139","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"issue":"1 Suppl","key":"10.1016\/j.trsl.2016.01.003_bib140","first-page":"e41","article-title":"US Renal Data System 2013 Annual Data Report: CKD in the general population","volume":"63","author":"Collins","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trsl.2016.01.003_bib141","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: a cross-sectional survey","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2016.01.003_bib142","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2016.01.003_bib143","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ki.2011.198","article-title":"Biomarkers in chronic kidney disease: a review","volume":"80","author":"Fassett","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2016.01.003_bib144","doi-asserted-by":"crossref","first-page":"569831","DOI":"10.1155\/2013\/569831","article-title":"Inflammatory factors and exercise in chronic kidney disease","volume":"2013","author":"Dungey","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.trsl.2016.01.003_bib145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.phrs.2014.02.007","article-title":"Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD)","volume":"81","author":"Impellizzeri","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.trsl.2016.01.003_bib146","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MNH.0b013e32834ad504","article-title":"Inflammation as a risk factor and target for therapy in chronic kidney disease","volume":"20","author":"Miyamoto","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.trsl.2016.01.003_bib147","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fphys.2012.00128","article-title":"Vascular inflammatory cells in hypertension","volume":"3","author":"Harrison","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.trsl.2016.01.003_bib148","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","article-title":"Inflammation, immunity, and hypertension","volume":"57","author":"Harrison","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2016.01.003_bib149","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/08037051.2014.940710","article-title":"Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers","volume":"24","author":"Barbaro","year":"2015","journal-title":"Blood Press"},{"key":"10.1016\/j.trsl.2016.01.003_bib150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00467-011-1772-6","article-title":"The origin of interstitial myofibroblasts in chronic kidney disease","volume":"27","author":"Grgic","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.trsl.2016.01.003_bib151","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00441-011-1275-6","article-title":"Role of TGF-\u03b2 in chronic kidney disease: an integration of tubular, glomerular and vascular effects","volume":"347","author":"L\u00f3pez-Hern\u00e1ndez","year":"2012","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.trsl.2016.01.003_bib152","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ijcard.2012.11.065","article-title":"Worldwide risk factors for heart failure: a systematic review and pooled analysis","volume":"168","author":"Khatibzadeh","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trsl.2016.01.003_bib153","first-page":"w13841","article-title":"Novel therapeutic options in inflammatory cardiomyopathy","volume":"143","author":"Kania","year":"2013","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.trsl.2016.01.003_bib154","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2016.01.003_bib155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2014.09.006","article-title":"Markers of fibrosis, inflammation, and remodeling pathways in heart failure","volume":"443","author":"Passino","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.trsl.2016.01.003_bib156","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/CVI.00281-12","article-title":"Differences in virus prevalence and load in the hearts of patients with idiopathic dilated cardiomyopathy with and without immune-mediated inflammatory diseases","volume":"19","author":"Dennert","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib157","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/heartjnl-2011-300960","article-title":"Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"98","author":"Kuusisto","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.trsl.2016.01.003_bib158","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0002-8703(89)90591-7","article-title":"Idiopathic dilated cardiomyopathy and atopic disease: epidemiologic evidence for an association with asthma","volume":"118","author":"Coughlin","year":"1989","journal-title":"Am Heart J"},{"key":"10.1016\/j.trsl.2016.01.003_bib159","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.yjmcc.2012.07.011","article-title":"Stem cell factor is responsible for the rapid response in mature mast cell density in the acutely stressed heart","volume":"53","author":"Li","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2016.01.003_bib160","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003-2012","volume":"313","author":"Aguilar","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2016.01.003_bib161","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbadis.2010.12.012","article-title":"Mast cells and metabolic syndrome","volume":"1822","author":"Zhang","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"SS02","key":"10.1016\/j.trsl.2016.01.003_bib162","first-page":"1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years\u2014autism and developmental disabilities monitoring network, 11 sites, United States, 2010","volume":"63","author":"Baio","year":"2014","journal-title":"Surveillance Summaries"},{"key":"10.1016\/j.trsl.2016.01.003_bib163","series-title":"Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey","author":"Zablotsky","year":"2015"},{"key":"10.1016\/j.trsl.2016.01.003_bib164","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbadis.2010.12.017","article-title":"Mast cell activation and autism","volume":"1822","author":"Theoharides","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2016.01.003_bib165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature10945","article-title":"De novo mutations revealed by whole-exome sequencing are strongly associated with autism","volume":"485","author":"Sanders","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2016.01.003_bib166","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","article-title":"Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"351","author":"Wakefield","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2016.01.003_bib167","doi-asserted-by":"crossref","first-page":"c7452","DOI":"10.1136\/bmj.c7452","article-title":"Wakefield's article linking MMR vaccine and autism was fraudulent","volume":"342","author":"Godlee","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.trsl.2016.01.003_bib168","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(10)60175-4","article-title":"Retraction\u2013ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2016.01.003_bib169","first-page":"CD004407","article-title":"Vaccines for measles, mumps and rubella in children","volume":"2","author":"Demicheli","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.trsl.2016.01.003_bib170","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/j.vaccine.2014.04.085","article-title":"Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies","volume":"32","author":"Taylor","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.trsl.2016.01.003_bib171","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1542\/peds.2014-1079","article-title":"Safety of vaccines used for routine immunization of U.S. children: a systematic review","volume":"134","author":"Maglione","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.trsl.2016.01.003_bib172","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s10067-015-3070-3","article-title":"HPV vaccination syndrome: a questionnaire-based study","volume":"34","author":"Mart\u00ednez-Lav\u00edn","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib173","doi-asserted-by":"crossref","first-page":"e3140","DOI":"10.1371\/journal.pone.0003140","article-title":"Lack of association between measles virus vaccine and autism with enteropathy: a case-control study","volume":"3","author":"Hornig","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.003_bib174","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1345\/aph.1Q318","article-title":"The vaccine-autism connection: a public health crisis caused by unethical medical practices and fraudulent science","volume":"45","author":"Flaherty","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.trsl.2016.01.003_bib175","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1398-9995.2010.02449.x","article-title":"Is atopic disease a risk factor for attention-deficit\/hyperactivity disorder? A systematic review","volume":"65","author":"Schmitt","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.01.003_bib176","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2012.10.041","article-title":"Mental health comorbidity in patients with atopic dermatitis","volume":"131","author":"Yaghmaie","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib177","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpsychores.2014.06.006","article-title":"Is atopy in early childhood a risk factor for ADHD and ASD? A longitudinal study","volume":"77","author":"Chen","year":"2014","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.trsl.2016.01.003_bib178","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/pai.12149","article-title":"Food allergy and food-based therapies in neurodevelopmental disorders","volume":"25","author":"de Theije","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib179","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(87)92534-7","article-title":"Tartrazine-induced histamine release from gastric mucosa","volume":"2","author":"Schaubschl\u00e4ger","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2016.01.003_bib180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13311-012-0133-x","article-title":"Artificial food colors and attention-deficit\/hyperactivity symptoms: conclusions to dye for","volume":"9","author":"Arnold","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.trsl.2016.01.003_bib181","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00787-014-0522-2","article-title":"Nutrition, immunological mechanisms and dietary immunomodulation in ADHD","volume":"23","author":"Verlaet","year":"2014","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.trsl.2016.01.003_bib182","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.iac.2014.02.001","article-title":"Neuropsychological features of adult mastocytosis","volume":"34","author":"Moura","year":"2014","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.trsl.2016.01.003_bib183","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaip.2013.09.004","article-title":"The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions","volume":"2","author":"Jennings","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.trsl.2016.01.003_bib184","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/svms.2003.36624","article-title":"Principles of treatment for mast cell tumors","volume":"18","author":"Govier","year":"2003","journal-title":"Clin Tech Small Anim Pract"},{"key":"10.1016\/j.trsl.2016.01.003_bib185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2460\/javma.2000.216.222","article-title":"Visceral mast cell tumors in dogs: 10 cases (1982-1997)","volume":"216","author":"Takahashi","year":"2000","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.trsl.2016.01.003_bib186","first-page":"1559","article-title":"Anxiety and depression: a common feature of health care seeking patients with irritable bowel syndrome and food allergy","volume":"45","author":"Addolorato","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.trsl.2016.01.003_bib187","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.2007.127068","article-title":"Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome","volume":"57","author":"Piche","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2016.01.003_bib188","first-page":"8010","article-title":"Anxiety and depression are associated with increased counts and degranulation of duodenal mast cells in functional dyspepsia","volume":"8","author":"Yuan","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib189","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1741-7015-11-200","article-title":"So depression is an inflammatory disease, but where does the inflammation come from?","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib191","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2174\/1871527313666141130224206","article-title":"Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review","volume":"13","author":"Skaper","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.trsl.2016.01.003_bib192","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/09513590.2014.911280","article-title":"Mast cells in chronic inflammation, pelvic pain and depression in women","volume":"30","author":"Graziottin","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.trsl.2016.01.003_bib193","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nn.4113","article-title":"Neuroimmune mechanisms of depression","volume":"18","author":"Hodes","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.trsl.2016.01.003_bib194","first-page":"75S","article-title":"Experimentally-induced allergy to tree pollen induces depressive-like behavior and mast cell activation in the brain of female rats","volume":"59","author":"Tonelli","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.trsl.2016.01.003_bib195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1590\/1516-4446-2012-0977","article-title":"Amitriptyline, clomipramine, and maprotiline attenuate the inflammatory response by inhibiting neutrophil migration and mast cell degranulation","volume":"35","author":"Gurgel","year":"2013","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.trsl.2016.01.003_bib196","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1289\/ehp.93101234","article-title":"Neurogenic inflammation and sensitivity to environmental chemicals","volume":"101","author":"Meggs","year":"1993","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.trsl.2016.01.003_bib197","doi-asserted-by":"crossref","first-page":"356235","DOI":"10.1155\/2013\/356235","article-title":"Allergological and toxicological aspects in a multiple chemical sensitivity cohort","volume":"2013","author":"Pigatto","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.trsl.2016.01.003_bib198","first-page":"367","article-title":"Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland","volume":"111","author":"Worm","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.trsl.2016.01.003_bib199","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbi.2015.07.002","article-title":"Mast cell activation disease: an underappreciated cause of neurologic and psychiatric symptoms and diseases","volume":"50","author":"Afrin","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.trsl.2016.01.003_bib200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1289\/ehp.9510354","article-title":"Neurogenic switching: a hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity","volume":"103","author":"Meggs","year":"1995","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.trsl.2016.01.003_bib201","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1191\/074823399678846844","article-title":"Mechanisms of allergy and chemical sensitivity","volume":"15","author":"Meggs","year":"1999","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.trsl.2016.01.003_bib202","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/all.12448","article-title":"EAACI position paper: irritant-induced asthma","volume":"69","author":"Vandenplas","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.01.003_bib203","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.3390\/ijerph8072770","article-title":"The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances","volume":"8","author":"De Luca","year":"2011","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.trsl.2016.01.003_bib204","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10548-015-0453-3","article-title":"Involvement of subcortical brain structures during olfactory stimulation in multiple chemical sensitivity","volume":"29","author":"Alessandrini","year":"2016","journal-title":"Brain Topogr"},{"key":"10.1016\/j.trsl.2016.01.003_bib205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.09.018","article-title":"A focus on mast cells and pain","volume":"264","author":"H\u00e9ron","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib206","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.psyneuen.2013.11.012","article-title":"An elevated pro-inflammatory cytokine profile in multiple chemical sensitivity","volume":"40","author":"Dantoft","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.trsl.2016.01.003_bib207","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/00039896.1996.9936026","article-title":"Prevalence and nature of allergy and chemical sensitivity in a general population","volume":"51","author":"Meggs","year":"1996","journal-title":"Arch Environ Health"},{"key":"10.1016\/j.trsl.2016.01.003_bib208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0748233709102713","article-title":"Asthma and chemical hypersensitivity: prevalence, etiology, and age of onset","volume":"25","author":"Caress","year":"2009","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.trsl.2016.01.003_bib209","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1191\/074823399680451759","article-title":"Links between multiple chemical sensitivity and asthma in a rat model of cholinergic hypersensitivity: a brief review","volume":"15","author":"Overstreet","year":"1999","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.trsl.2016.01.003_bib210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/00039890009603420","article-title":"Mast cell disorder to be ruled out in MCS","volume":"55","author":"Heuser","year":"2000","journal-title":"Arch Environ Health"},{"key":"10.1016\/j.trsl.2016.01.003_bib211","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.hoc.2014.04.005","article-title":"Anemia of inflammation","volume":"28","author":"Nemeth","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.trsl.2016.01.003_bib212","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood-2004-05-1812","article-title":"Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia","volume":"104","author":"Guralnik","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib213","first-page":"1075","article-title":"Neuroimmune mechanisms in health and disease: 2. Disease","volume":"155","author":"Anisman","year":"1996","journal-title":"CMAJ"},{"key":"10.1016\/j.trsl.2016.01.003_bib214","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1182\/blood.V122.21.5240.5240","article-title":"Characterization of common blood test abnormalities potentially aiding diagnosis of mast cell activation syndrome: a preliminary analysis","volume":"122","author":"Afrin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib215","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib216","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.bcp.2008.12.018","article-title":"Linking anemia to inflammation and cancer: the crucial role of TNFalpha","volume":"77","author":"Buck","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trsl.2016.01.003_bib217","doi-asserted-by":"crossref","first-page":"e45667","DOI":"10.1371\/journal.pone.0045667","article-title":"Iron supplementation decreases severity of allergic inflammation in murine lung","volume":"7","author":"Hale","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.003_bib218","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJMsa1504267","article-title":"Emergency department visits for adverse events related to dietary supplements","volume":"373","author":"Geller","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib219","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1185\/03007995.2012.761599","article-title":"Tolerability of different oral iron supplements: a systematic review","volume":"29","author":"Cancelo-Hidalgo","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.trsl.2016.01.003_bib220","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.crohns.2011.09.010","article-title":"Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis","volume":"6","author":"Lee","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.trsl.2016.01.003_bib221","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1002\/ajh.23322","article-title":"Comparative rates of adverse events with different formulations of intravenous iron","volume":"87","author":"Okam","year":"2012","journal-title":"Am J Hematol"},{"issue":"S1","key":"10.1016\/j.trsl.2016.01.003_bib222","first-page":"374","article-title":"The disproportionate analysis of intravenous iron-containing medicines related adverse reactions in Taiwan","volume":"23","author":"Huang","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.trsl.2016.01.003_bib223","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev.immunol.26.021607.090320","article-title":"The master switch: the role of mast cells in autoimmunity and tolerance","volume":"26","author":"Sayed","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib224","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1586\/1744666X.2015.1077702","article-title":"Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome","volume":"11","author":"Kon\u00e9-Paut","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib225","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.immuni.2012.04.013","article-title":"Critical role for mast cells in interleukin-1\u03b2-driven skin inflammation associated with an activating mutation in the nlrp3 protein","volume":"37","author":"Nakamura","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2016.01.003_bib226","series-title":"Endometriosis: advanced management and surgical techniques","first-page":"3","article-title":"Chapter 1: Epidemiology of endometriosis","author":"Berger","year":"1995"},{"key":"10.1016\/j.trsl.2016.01.003_bib227","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/humupd\/dmt016","article-title":"Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review","volume":"19","author":"Janssen","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.trsl.2016.01.003_bib228","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.humrep.a138650","article-title":"Gruppo italiano per lo studio dell'endometriosi. Endometriosis: prevalence and anatomical distribution of endometriosis in women with selected gynaecological conditions: results from a multicentric Italian study","volume":"9","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.trsl.2016.01.003_bib229","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-8545(05)70302-8","article-title":"Epidemiology of endometriosis","volume":"24","author":"Eskenazi","year":"1997","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.trsl.2016.01.003_bib230","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1093\/humrep\/dep231","article-title":"Medical treatment for rectovaginal endometriosis: what is the evidence?","volume":"24","author":"Vercellini","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.trsl.2016.01.003_bib231","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.fertnstert.2011.05.090","article-title":"Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries","volume":"96","author":"Nnoaham","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2016.01.003_bib232","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijsu.2013.02.003","article-title":"The \u2018evil twin syndrome\u2019 in chronic pelvic pain: a systematic review of prevalence studies of bladder pain syndrome and endometriosis","volume":"11","author":"Tirlapur","year":"2013","journal-title":"Int J Surg"},{"key":"10.1016\/j.trsl.2016.01.003_bib233","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.61.3.273","article-title":"Interstitial cystitis and panic disorder: a potential genetic syndrome","volume":"61","author":"Weissman","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.trsl.2016.01.003_bib234","first-page":"75","article-title":"Targeting mast cells in endometriosis with Janus kinase 3 inhibitor, JANEX-1","volume":"58","author":"D'Cruz","year":"2007","journal-title":"Am J Reprod Endocrinol"},{"key":"10.1016\/j.trsl.2016.01.003_bib235","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.fertnstert.2006.03.057","article-title":"Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis","volume":"86","author":"Anaf","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2016.01.003_bib236","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0897.2004.00224.x","article-title":"Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin","volume":"52","author":"Kempuraj","year":"2004","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib237","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/S1074-3804(02)80250-X","article-title":"Increased activated mast cells in stromal lesions of human endometriosis","volume":"9","author":"Uchiide","year":"2002","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"10.1016\/j.trsl.2016.01.003_bib238","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.fertnstert.2009.02.016","article-title":"Novel finding of high density of activated mast cells in endometrial polyps","volume":"92","author":"Al-Jefout","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.trsl.2016.01.003_bib239","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1210\/jc.2014-1214","article-title":"Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study","volume":"99","author":"Palomba","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2016.01.003_bib240","first-page":"124","article-title":"Study of the mast cells distribution and heterogeneity in experimentally induced cystic ovaries in rats","volume":"8","author":"Razi","year":"2010","journal-title":"Int J Appl Res Vet Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib241","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/0194599812473241","article-title":"Effects of polycystic ovary syndrome and menopause on rat soft palate and base of tongue","volume":"148","author":"Deveci","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.trsl.2016.01.003_bib242","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.mcg.0000190644.01661.2b","article-title":"Celiac disease: current concepts in diagnosis and treatment","volume":"40","author":"Chand","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib243","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0002-9343(89)80399-7","article-title":"Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease","volume":"87","author":"Lav\u00f6","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib244","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/gut.24.3.222","article-title":"Human intestinal mucosal mast cells: expanded population in untreated coeliac disease","volume":"24","author":"Strobel","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2016.01.003_bib245","first-page":"370","article-title":"Intestinal mast cells in different stages of celiac disease","volume":"22","author":"Suranyi","year":"1986","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.trsl.2016.01.003_bib246","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00251-002-0498-9","article-title":"TNF alpha and LT alpha gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive population","volume":"54","author":"Garrote","year":"2002","journal-title":"Immunogenetics"},{"key":"10.1016\/j.trsl.2016.01.003_bib247","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molimm.2014.06.018","article-title":"The role of the IL-33\/IL-1RL1 axis in mast cell and basophil activation in allergic disorders","volume":"63","author":"Saluja","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib248","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/08916930903540432","article-title":"Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil","volume":"43","author":"Pontillo","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.trsl.2016.01.003_bib249","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/ajg.2010.474","article-title":"The missense variation Q705K in CIAS1\/NALP3\/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease","volume":"106","author":"Pontillo","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib250","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbadis.2009.01.007","article-title":"Tumor necrosis factor alpha-308 gene locus promoter polymorphism: an analysis of association with health and disease","volume":"1792","author":"Elahi","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2016.01.003_bib251","doi-asserted-by":"crossref","first-page":"22381","DOI":"10.1073\/pnas.0906372106","article-title":"Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase\/Mcpt4-dependent mechanism","volume":"106","author":"Groschwitz","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.01.003_bib252","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0016-5085(98)70134-9","article-title":"Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease","volume":"115","author":"Nilsen","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2016.01.003_bib253","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ajg.2013.91","article-title":"Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity","volume":"108","author":"Brottveit","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib254","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/gut.36.6.874","article-title":"Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody","volume":"36","author":"Przemioslo","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2016.01.003_bib255","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/gast.1996.v110.pm8613040","article-title":"Definition of the initial immunologic modifications upon in\u00a0vitro gliadin challenge in the small intestine of celiac patients","volume":"110","author":"Maiuri","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2016.01.003_bib256","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1684\/ejd.2013.2158","article-title":"Does urticaria risk increase in patients with celiac disease? A large population-based cohort study","volume":"23","author":"Ludvigsson","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib257","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.annepidem.2009.11.007","article-title":"Subsequent autoimmune or related disease in asthma patients: clustering of diseases or medical care?","volume":"20","author":"Hemminki","year":"2010","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.trsl.2016.01.003_bib258","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1155\/2006\/871987","article-title":"Chronic urticaria: a cutaneous manifestation of celiac disease","volume":"20","author":"Haussmann","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib259","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1542\/peds.104.2.e25","article-title":"Celiac disease associated with familial chronic urticaria and thyroid autoimmunity in a child","volume":"104","author":"Levine","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.trsl.2016.01.003_bib260","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s10620-005-2919-8","article-title":"Idiopathic chronic urticaria and celiac disease","volume":"50","author":"Gabrielli","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.trsl.2016.01.003_bib261","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ajg.2010.487","article-title":"Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial","volume":"106","author":"Biesiekierski","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib262","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/ajg.2009.188","article-title":"Between celiac disease and irritable bowel syndrome: the \u201cno man's land\u201d of gluten sensitivity","volume":"104","author":"Verdu","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.003_bib263","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1111\/1523-1747.ep12469015","article-title":"The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosis","volume":"96","author":"Miner","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib264","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/PAS.0b013e318078ce7a","article-title":"Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis","volume":"31","author":"Hahn","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.trsl.2016.01.003_bib265","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/PAS.0000000000000190","article-title":"A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients","volume":"38","author":"Doyle","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.trsl.2016.01.003_bib266","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11916-009-0040-y","article-title":"Migraine pain, meningeal inflammation, and mast cells","volume":"13","author":"Levy","year":"2009","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.trsl.2016.01.003_bib267","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1017\/S1462399411002067","article-title":"Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation","volume":"13","author":"Raddant","year":"2011","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib268","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1526-4610.1963.hed0303086.x","article-title":"Mast cells and their active substances: their role in the pathogenesis of migraine","volume":"3","author":"Sicuteri","year":"1963","journal-title":"Headache"},{"key":"10.1016\/j.trsl.2016.01.003_bib269","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1353\/pbm.1983.0028","article-title":"Brief proposal: mast cells and migraines","volume":"26","author":"Theoharides","year":"1983","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresrev.2004.11.006","article-title":"The role of mast cells in migraine pathophysiology","volume":"49","author":"Theoharides","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.trsl.2016.01.003_bib271","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1210\/endo.136.12.7588332","article-title":"Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect","volume":"136","author":"Theoharides","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2016.01.003_bib272","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)01855-7","article-title":"Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in\u00a0vitro and in\u00a0vivo","volume":"849","author":"Rozniecki","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.trsl.2016.01.003_bib273","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1124\/jpet.107.123745","article-title":"Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators","volume":"322","author":"Zhang","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2016.01.003_bib274","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00221-009-1756-y","article-title":"Migraine: where and how does the pain originate?","volume":"196","author":"Messlinger","year":"2009","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.trsl.2016.01.003_bib275","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WCO.0b013e328360864b","article-title":"Prostaglandins in migraine: update","volume":"26","author":"Antonova","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.trsl.2016.01.003_bib276","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/mi.5.5.10","article-title":"Neurogenic inflammation and migraine: implications for the therapeutics","volume":"5","author":"Peroutka","year":"2005","journal-title":"Mol Interv"},{"key":"10.1016\/j.trsl.2016.01.003_bib277","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1526-4610.2008.01215.x","article-title":"Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine","volume":"48","author":"Durham","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.trsl.2016.01.003_bib278","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-pharmtox-010814-124701","article-title":"Calcitonin gene-related peptide (CGRP): a new target for migraine","volume":"55","author":"Russo","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.trsl.2016.01.003_bib279","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1526-4610.2008.00852.x","article-title":"Mast cells activate the renin angiotensin system and contribute to migraine: a hypothesis","volume":"48","author":"Ba'albaki","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.trsl.2016.01.003_bib280","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/039463201302600303","article-title":"Impact of capsaicin on mast cell inflammation","volume":"26","author":"Frydas","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.trsl.2016.01.003_bib281","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","article-title":"Mast cell activation contributes to sickle cell pathobiology and pain in mice","volume":"122","author":"Vincent","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib282","doi-asserted-by":"crossref","first-page":"857123","DOI":"10.1155\/2012\/857123","article-title":"Stimulation of TRPV1 by green laser light","volume":"2012","author":"Gu","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib283","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-3565(24)35050-5","article-title":"Differential effect of histamine 3 receptor-active agents on brain, but not peritoneal, mast cell activation","volume":"290","author":"Rozniecki","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2016.01.003_bib284","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1526-4610.2007.00784.x","article-title":"Endometriosis is associated with prevalence of comorbid conditions in migraine","volume":"47","author":"Tietjen","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.trsl.2016.01.003_bib285","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/head.12731","article-title":"Asthma is a risk factor for new onset chronic migraine: results from the American migraine prevalence and prevention study","volume":"56","author":"Martin","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.trsl.2016.01.003_bib286","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.0506104103","article-title":"Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus","volume":"103","author":"Yoshimoto","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.01.003_bib287","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2014.03.001","article-title":"Mast cells: versatile gatekeepers of pain","volume":"63","author":"Chatterjea","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib288","doi-asserted-by":"crossref","first-page":"29069","DOI":"10.3390\/ijms161226151","article-title":"Mast cell-mediated mechanisms of nociception","volume":"16","author":"Aich","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2016.01.003_bib289","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib290","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.smrv.2011.09.003","article-title":"Restless legs syndrome\u2014theoretical roles of inflammatory and immune mechanisms","volume":"16","author":"Weinstock","year":"2012","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.trsl.2016.01.003_bib291","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/JCP.0b013e318239c190","article-title":"Decreased mitochondrial function and increased brain inflammation in bipolar disorder and other neuropsychiatric diseases","volume":"31","author":"Theoharides","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.trsl.2016.01.003_bib292","first-page":"147","article-title":"Mast cell serotonin immunoregulatory effects impacting on neuronal function: implications for neurodegenerative and psychiatric disorders","volume":"28","author":"Conti","year":"2015","journal-title":"i"},{"key":"10.1016\/j.trsl.2016.01.003_bib293","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1054\/mehy.1997.0671","article-title":"Histamine and prostaglandins in schizophrenia: revisited","volume":"52","author":"Heleniak","year":"1999","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.trsl.2016.01.003_bib294","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1517\/14728220903188438","article-title":"Histamine H3 and H4 receptors as novel drug targets","volume":"18","author":"Tiligada","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.trsl.2016.01.003_bib295","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0074-7742(06)78009-6","article-title":"Histamine and schizophrenia","volume":"78","author":"Arrang","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.trsl.2016.01.003_bib296","series-title":"The human histaminergic system in health and neuropsychiatric disorders","article-title":"Chapter 9: increased expression of histamine methyltransferase-mRNA and astrocyte markers in the prefrontal cortex in schizophrenia","author":"Shan","year":"2012"},{"key":"10.1016\/j.trsl.2016.01.003_bib297","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-387718-5.00007-9","article-title":"Immune and neuroimmune alterations in mood disorders and schizophrenia","volume":"101","author":"Drexhage","year":"2011","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.trsl.2016.01.003_bib298","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1096\/fj.11-197194","article-title":"Microglia and mast cells: two tracks on the road to neuroinflammation","volume":"26","author":"Skaper","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2016.01.003_bib299","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000135642","article-title":"Association of tumor necrosis factor -308G\/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population","volume":"57","author":"Czerski","year":"2008","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.trsl.2016.01.003_bib300","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ddr.10290","article-title":"Toward schizophrenia genes: genetics and transcriptome","volume":"60","author":"Ito","year":"2003","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.trsl.2016.01.003_bib301","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00045391-200301000-00014","article-title":"Comorbidity of irritable bowel syndrome in psychiatric patients: a review","volume":"10","author":"Garakani","year":"2003","journal-title":"Am J Ther"},{"key":"10.1016\/j.trsl.2016.01.003_bib302","doi-asserted-by":"crossref","first-page":"e002808","DOI":"10.1136\/bmjopen-2013-002808","article-title":"Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study","volume":"3","author":"Smith","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.trsl.2016.01.003_bib303","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/schbul\/sbn135","article-title":"Psychiatric comorbidities and schizophrenia","volume":"35","author":"Buckley","year":"2009","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.trsl.2016.01.003_bib304","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2006.07.006","article-title":"High rates of comorbidity are found in childhood-onset schizophrenia","volume":"88","author":"Ross","year":"2006","journal-title":"Schizophr Res"},{"issue":"Suppl","key":"10.1016\/j.trsl.2016.01.003_bib305","first-page":"S67","article-title":"Medical comorbidity in schizophrenia","volume":"178","author":"Lambert","year":"2003","journal-title":"Med J Aust"},{"key":"10.1016\/j.trsl.2016.01.003_bib306","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1525-1497.2006.00563.x","article-title":"Medical comorbidity in women and men with schizophrenia: a population-based controlled study","volume":"21","author":"Carney","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib307","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.mp.4002003","article-title":"Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia","volume":"12","author":"Christoforou","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.trsl.2016.01.003_bib308","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.12.049","article-title":"Can bipolar disorder be viewed as a multi-system inflammatory disease?","volume":"141","author":"Leboyer","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.trsl.2016.01.003_bib309","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jad.2015.08.036","article-title":"Peripheral inflammation during abnormal mood states in bipolar I disorder","volume":"187","author":"Fiedorowicz","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.trsl.2016.01.003_bib310","doi-asserted-by":"crossref","first-page":"708306","DOI":"10.1155\/2015\/708306","article-title":"Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder?","volume":"2015","author":"Patel","year":"2015","journal-title":"Neural Plast"},{"key":"10.1016\/j.trsl.2016.01.003_bib311","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jad.2015.03.013","article-title":"Neurokinin (NK)-1 receptor expression in monocytes from bipolar disorder patients: a pilot study","volume":"178","author":"Amoruso","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.trsl.2016.01.003_bib312","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neuro.2009.03.004","article-title":"The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?","volume":"30","author":"Soczynska","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.trsl.2016.01.003_bib313","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.mehy.2012.11.043","article-title":"Angiotensin receptor blockers for bipolar disorder","volume":"80","author":"de G\u00f3is Queiroz","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.trsl.2016.01.003_bib314","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/2347-8659.167304","article-title":"Neuroinflammation and excitatory symptoms in bipolar disorder","volume":"2","author":"Panaccione","year":"2015","journal-title":"Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.trsl.2016.01.003_bib315","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mcn.2012.10.002","article-title":"The role of the innate immune system in psychiatric disorders","volume":"53","author":"Jones","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.trsl.2016.01.003_bib316","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/0004867413499077","article-title":"Immune dysregulation and autoimmunity in bipolar disorder: synthesis of the evidence and its clinical application","volume":"47","author":"Rege","year":"2013","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.trsl.2016.01.003_bib317","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000356539","article-title":"The immunology of bipolar disorder","volume":"21","author":"Barbosa","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.trsl.2016.01.003_bib318","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.trsl.2016.01.003_bib319","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.trsl.2016.01.003_bib320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2478\/s13380-011-0019-0","article-title":"Recent advances in psychoneuroimmunology: inflammation in psychiatric disorders","volume":"2","author":"Debnath","year":"2011","journal-title":"Transl Neurosci"},{"key":"10.1016\/j.trsl.2016.01.003_bib321","first-page":"374","article-title":"The pathology of lithium induced nephropathy: a case report and review, with emphasis on the demonstration of mast cells","volume":"7","author":"Kumarguru","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.trsl.2016.01.003_bib322","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/gps.4048","article-title":"The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder","volume":"29","author":"Lotrich","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.trsl.2016.01.003_bib323","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.euroneuro.2015.04.023","article-title":"CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment","volume":"25","author":"Rolstad","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.trsl.2016.01.003_bib324","doi-asserted-by":"crossref","first-page":"408136","DOI":"10.1155\/2015\/408136","article-title":"The potential role of the NLRP3 inflammasome as a link between mitochondrial complex I dysfunction and inflammation in bipolar disorder","volume":"2015","author":"Kim","year":"2015","journal-title":"Neural Plast"},{"key":"10.1016\/j.trsl.2016.01.003_bib325","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/jamapsychiatry.2013.1111","article-title":"Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study","volume":"70","author":"Benros","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.trsl.2016.01.003_bib326","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/cn500038f","article-title":"Effects of lithium on inflammation","volume":"5","author":"Nassar","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.trsl.2016.01.003_bib327","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/cipms-2015-0054","article-title":"Bipolar affective disorder: a review of novel forms of therapy","volume":"28","author":"Dziwota","year":"2015","journal-title":"Curr Issues Pharm Med Sci"},{"key":"10.1016\/j.trsl.2016.01.003_bib328","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1286-4579(99)00250-6","article-title":"TGF-beta and fibrosis","volume":"1","author":"Branton","year":"1999","journal-title":"Microbes Infect"},{"key":"10.1016\/j.trsl.2016.01.003_bib329","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2222.2002.01293.x","article-title":"Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis","volume":"32","author":"Garbuzenko","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.01.003_bib330","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00007890-199205000-00015","article-title":"The relationship of mast cells and their secreted products to the volume of fibrosis in posttransplant hearts","volume":"53","author":"Li","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.trsl.2016.01.003_bib331","first-page":"151","article-title":"Quantitation of mast cells in 100 normal and 92 diseased human hearts. Implications for interpretation of endomyocardial biopsy specimens","volume":"2","author":"Turlington","year":"1988","journal-title":"Am J Cardiovasc Pathol"},{"key":"10.1016\/j.trsl.2016.01.003_bib332","first-page":"717","article-title":"Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders","volume":"40","author":"Kawanami","year":"1979","journal-title":"Lab Invest"},{"key":"10.1016\/j.trsl.2016.01.003_bib333","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/jcp.53.11.858","article-title":"Mast cells: the forgotten cells of renal fibrosis","volume":"53","author":"Roberts","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.trsl.2016.01.003_bib334","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-1568-2_7","article-title":"Mast cells in human health and disease","volume":"1220","author":"DeBruin","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.trsl.2016.01.003_bib335","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0168-8278(97)80113-4","article-title":"Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis","volume":"26","author":"Armbrust","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib336","first-page":"1135","article-title":"Mast cells and pancreatic stellate cells in chronic pancreatitis with differently intensified fibrosis","volume":"49","author":"Zimnoch","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.trsl.2016.01.003_bib337","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1093\/ndt\/gfs408","article-title":"Eotaxin\/CCL11 in idiopathic retroperitoneal fibrosis","volume":"27","author":"Mangieri","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2016.01.003_bib338","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2120::AID-CNCR10>3.0.CO;2-C","article-title":"Clinical correlates of the presence of the asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis","volume":"83","author":"Worobec","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.trsl.2016.01.003_bib339","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/jcp.28.12.947","article-title":"Quantitative observations on iliac bone marrow mast cells in chronic renal failure","volume":"28","author":"Peart","year":"1975","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.trsl.2016.01.003_bib340","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2559.1979.tb03017.x","article-title":"Mast cells and mast cell neoplasia: a review","volume":"3","author":"Lennert","year":"1979","journal-title":"Histopathology"},{"key":"10.1016\/j.trsl.2016.01.003_bib341","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.prp.2011.12.005","article-title":"Sclerosing mediastinitis and mast cell activation syndrome","volume":"208","author":"Afrin","year":"2012","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.trsl.2016.01.003_bib342","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.msard.2015.11.005","article-title":"Important role of mast cells in multiple sclerosis","volume":"5","author":"Conti","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.trsl.2016.01.003_bib343","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2174\/1871527314666150716103629","article-title":"Defining and regulating acute inflammatory lesion formation during the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"14","author":"Bolton","year":"2015","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.trsl.2016.01.003_bib344","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2014.12.009","article-title":"Dynamic changes in meningeal inflammation correspond to clinical exacerbations in a murine model of relapsing-remitting multiple sclerosis","volume":"278","author":"Walker-Caulfield","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib345","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.trsl.2014.08.005","article-title":"The meninges: new therapeutic targets for multiple sclerosis","volume":"165","author":"Russi","year":"2015","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2016.01.003_bib346","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib347","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fphar.2013.00174","article-title":"Are mast cells instrumental for fibrotic diseases?","volume":"4","author":"Overed-Sayer","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.trsl.2016.01.003_bib348","series-title":"Myelodysplastic syndromes","first-page":"41","article-title":"Cytogenetic diagnosis of myelodysplastic syndromes","author":"Olney","year":"2013"},{"key":"10.1016\/j.trsl.2016.01.003_bib349","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1939-1676.2006.tb02871.x","article-title":"Comparison of four staining methods for detection of mast cells in equine bronchoalveolar lavage fluid","volume":"20","author":"Leclere","year":"2006","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib350","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1128\/MCB.25.14.6199-6210.2005","article-title":"Loss of histochemical identity in mast cells lacking carboxypeptidase A","volume":"25","author":"Feyerabend","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2016.01.003_bib351","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clinthera.2013.02.022","article-title":"Coronary hypersensitivity disorder: the Kounis syndrome","volume":"35","author":"Kounis","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.trsl.2016.01.003_bib352","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1586\/eci.10.47","article-title":"Current understanding of Kounis syndrome","volume":"6","author":"Biteker","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib353","first-page":"1","article-title":"Kounis syndrome: a monster for the atopic patient","volume":"3","author":"Kounis","year":"2013","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.trsl.2016.01.003_bib354","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/eurheartj\/ehl032","article-title":"Apical ballooning syndrome or Takotsubo cardiomyopathy: a systematic review","volume":"27","author":"Gianni","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.trsl.2016.01.003_bib355","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.ijcard.2007.08.022","article-title":"A case of Takotsubo cardiomyopathy associated with Kounis syndrome","volume":"132","author":"Yanagawa","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trsl.2016.01.003_bib356","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejheart.2006.05.011","article-title":"Tako-Tsubo-like syndrome during anaphylactic reaction","volume":"9","author":"Vultaggio","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.trsl.2016.01.003_bib357","first-page":"1301","article-title":"Burning mouth syndrome","volume":"2010","author":"Buchanan","year":"2010","journal-title":"BMJ Clin Evid"},{"key":"10.1016\/j.trsl.2016.01.003_bib358","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.HYP.0000158259.68614.40","article-title":"Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders","volume":"45","author":"Shibao","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2016.01.003_bib359","first-page":"84","article-title":"The postural tachycardia syndrome (POTS): pathophysiology, diagnosis and management","volume":"6","author":"Raj","year":"2006","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.trsl.2016.01.003_bib360","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MAJ.0000000000000325","article-title":"Mast cell activation syndrome as a significant comorbidity in sickle cell disease","volume":"348","author":"Afrin","year":"2014","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.trsl.2016.01.003_bib361","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1182\/blood.V126.23.5194.5194","article-title":"Utility of continuous diphenhydramine infusion in\u00a0severe mast cell activation syndrome","volume":"126","author":"Afrin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib362","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0272-6386(98)70022-8","article-title":"Tubulointerstitial mast cell infiltration in glomerulonephritis","volume":"32","author":"Hiromura","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trsl.2016.01.003_bib363","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1681\/ASN.2005080799","article-title":"A pathogenetic role for mast cells in experimental crescentic glomerulonephritis","volume":"17","author":"Timoshanko","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"1-6","key":"10.1016\/j.trsl.2016.01.003_bib364","first-page":"437","article-title":"Factor VIII-related antigen and mast cells","volume":"90A","author":"Kindblom","year":"1982","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.trsl.2016.01.003_bib365","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1440-1827.1991.tb01657.x","article-title":"Immunohistochemical characterization of human cutaneous mast cells in urticaria pigmentosa (cutaneous mastocytosis)","volume":"41","author":"Akiyama","year":"1991","journal-title":"Pathol Int"},{"key":"10.1016\/j.trsl.2016.01.003_bib366","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1538-7836.2011.04198.x","article-title":"Association between atopic diseases and venous thromboembolism: a case-control study in patients aged 45 years or less","volume":"9","author":"Undas","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2016.01.003_bib367","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0190-9622(99)70193-3","article-title":"Chronic urticaria and angioedema associated with thyroid autoimmunity: review and therapeutic implications","volume":"40","author":"Heymann","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trsl.2016.01.003_bib368","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.88.6.517","article-title":"Chronic urticaria: association with thyroid autoimmunity","volume":"88","author":"Levy","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.trsl.2016.01.003_bib369","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/endo-90-3-802","article-title":"Significance of thyroid mast cells in thyroid hormone secretion","volume":"90","author":"Melander","year":"1972","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2016.01.003_bib370","first-page":"501","article-title":"Role of mast cells in health: daily rhythmic variations in their number, exocytotic activity, histamine and serotonin content in the rat thyroid gland","volume":"36","author":"Catini","year":"1992","journal-title":"Eur J Histochem"},{"key":"10.1016\/j.trsl.2016.01.003_bib371","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood.V126.23.986.986","article-title":"Characteristics and potential biomarkers for chronic pain in patients with sickle cell disease","volume":"126","author":"Kuei","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib372","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1182\/blood-2013-07-510982","article-title":"GLEE-ful for sickle cell pain?","volume":"122","author":"Kutlar","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.003_bib373","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s12185-010-0605-x","article-title":"Mast cell activation disorder masquerading as pure red cell aplasia","volume":"91","author":"Afrin","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.trsl.2016.01.003_bib374","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7205\/MILMED-D-11-00111","article-title":"Mast cell activation syndrome masquerading as agranulocytosis","volume":"177","author":"Afrin","year":"2012","journal-title":"Mil Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib375","doi-asserted-by":"crossref","first-page":"AB65","DOI":"10.1016\/j.jaci.2014.12.1146","article-title":"A new disease cluster: mast cell activation syndrome, postural orthostatic tachycardia syndrome, and Ehlers-Danlos syndrome","volume":"135","author":"Cheung","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib376","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.mayocp.2012.08.013","article-title":"Postural tachycardia syndrome: a heterogeneous and multifactorial disorder","volume":"87","author":"Benarroch","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.trsl.2016.01.003_bib377","first-page":"A12","article-title":"Prevalence of allergic disorders and mast cell activation syndrome and in patients with Ehlers Danlos syndrome","volume":"111","author":"Louisias","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib378","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11910-015-0583-8","article-title":"Postural tachycardia syndrome: beyond orthostatic intolerance","volume":"15","author":"Garland","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.trsl.2016.01.003_bib379","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrneurol.2011.187","article-title":"Postural tachycardia syndrome\u2013current experience and concepts","volume":"8","author":"Mathias","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.trsl.2016.01.003_bib380","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","article-title":"Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities","volume":"133","author":"Lyons","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib381","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/jclinpath-2014-202488","article-title":"Cronkhite-Canada syndrome six decades on: the many faces of an enigmatic disease","volume":"67","author":"Slavik","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.trsl.2016.01.003_bib382","first-page":"S46","article-title":"The Cronkhite-Canada syndrome: evidence for gut mast cell involvement","volume":"103","author":"Van Dellen","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.003_bib383","doi-asserted-by":"crossref","first-page":"148795","DOI":"10.1155\/2009\/148795","article-title":"Cronkhite-Canada syndrome: gastric involvement diagnosed by MDCT","volume":"2009","author":"Samet","year":"2009","journal-title":"Case Rep Med"},{"key":"10.1016\/j.trsl.2016.01.003_bib384","first-page":"124","article-title":"A rapid clinical response to anti-tumor necrosis factor alpha therapy in refractory Cronkhite-Canada syndrome","volume":"29","author":"Myint","year":"2014","journal-title":"Luminal Clin J Gastroenterol Hepatol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:49:49Z","timestamp":1748753389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524416000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":384,"alternative-id":["S1931524416000220"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2016.01.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cell activation disease and the modern epidemic of chronic inflammatory disease","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}